marketing-medtech

**Founder:** Yannick Gazeuse — Président (SAS)
**Background:** unknown | verified: False — Unverified. No real source was found confirming the professional background of a "Yannick Gazeuse" as Président of MADIN.AI HEALTH (SAS). The company "MADIN.AI HEALTH" did not surface in French business registry searches (Pappers, societe.com, verif.com), and no LinkedIn, press, or official profile connects a Yannick Gazeuse to that company or describes his background. A person named "Yannick Gazeuse" appears only in passing in French healthcare/hospital-emergency AI-deployment contexts, but with no documented role at MADIN.AI HEALTH and no stated professional history, so the background cannot be established.
**Stage / fundraise:** Pre-seed / brand-new. Incorporated 2025-12-02 (about 7 months old as of June 2026), 0 employees, SAS legal form. NAF 72.19Z (other scientific/technical R&D) with secondary 72.10H, consistent with an early R&D-stage AI venture rather than a trading entity. / No fundraising confirmed. No funding round, grant, BPI/French Tech, or press announcement found. Recency and a name ending in ".AI HEALTH" suggest a pre-seed posture, but "actively fundraising" is NOT verifiable from public sources.
**Regulatory trigger:** Speculative only. The name implies an AI-in-health product that, if it qualifies as Software as a Medical Device, would face IEC 62304 / MDR obligations. However, there is NO public evidence of a product, an intended medical-device classification, or any CE/reimbursement milestone. Treat the regulatory trigger as unconfirmed.
**Email:** (confidence none) — No published email address and no confirmed company domain were found (no website located), so no address can be guessed or pattern-derived without fabrication. Left blank per hard rules.
**LinkedIn:** **Website:**
**Score:** 5 -> Tier C
**Hook:** A days-old AI-health SAS in Martinique with no employees yet: the entire build (and the IEC 62304/MDR evidence trail) is still ahead of you. OmDev gives a brand-new founder a senior dev team plus a dedicated CTO at a fixed monthly price ~3x cheaper than recruiting that team in-house — especially hard to hire in an overseas territory — and our pipeline produces the SOUP register and requirements-to-code-to-test traceability that feed your future MDR file, while you keep full ownership of the code.

---

## Founder & background
Yannick Gazeuse (born June 1986) is the Président of the SAS, per the French company registry. No LinkedIn, press, or prior-company record confirming his professional background could be found, so his profile is **unknown** (no finance/insurance/pharma/tech claim is supportable). A "Gaze Yannick" LinkedIn (Réunion) surfaced but the surname differs and it cannot be confirmed. Source: [recherche-entreprises.api.gouv.fr](https://recherche-entreprises.api.gouv.fr/search?q=994629426).

## Funding & momentum
Incorporated **2025-12-02** (SIREN 994629426), so roughly 7 months old as of June 2026 — well inside the early ICP window. **0 declared employees**, SAS form, NAF 72.19Z (scientific/technical R&D). No funding round, grant, or French Tech/BPI signal found; "actively fundraising" is plausible for a pre-seed AI venture but **not verifiable**. Source: [registry](https://recherche-entreprises.api.gouv.fr/search?q=994629426).

## Product & regulatory
No website or product could be located; the name suggests an AI-in-health SaaS, likely Martinique-focused ("Madin"). **Note: the registry lists Saint-Joseph, 97212 — Martinique, not La Réunion** as the candidate guess stated. If the product becomes SaMD it would face IEC 62304 / MDR, but there is no public evidence of a product, classification, or CE/reimbursement milestone — the regulatory trigger is speculative. Martinique has an active digital-health ecosystem (e.g. the MADIN'e-santé conference), context only. Source: [ARS Martinique](https://www.martinique.ars.sante.fr/evenement-madine-sante-2025-journees-du-numerique-en-sante-les-13-et-14-mars-madiana-reservez-des).

## Pain & buying signals
Brand-new SAS, 0 employees, no online footprint — strongly implies no in-house engineering and no CTO yet, and any SaMD compliance work is entirely greenfield. Overseas-territory base compounds the difficulty of hiring senior devs/CTO. The clear pain is build capacity + compliance scaffolding from zero.

**Why OmDev fits:** For a pre-seed founder with no team, OmDev supplies a senior dev squad + dedicated CTO at a fixed monthly price ~3x cheaper than building in-house — and our regulated-medtech pipeline emits the SOUP register and requirements-to-code-to-test traceability that feed the IEC 62304/MDR file (OmDev does not certify), with the client owning the code. **Caveat:** founder background, fundraising, and product are all unconfirmed and there is no reachable contact — qualify before outreach; Tier C.

---
**Sources:** https://recherche-entreprises.api.gouv.fr/search?q=994629426 · https://www.martinique.ars.sante.fr/evenement-madine-sante-2025-journees-du-numerique-en-sante-les-13-et-14-mars-madiana-reservez-des